Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock

被引:62
|
作者
Hohn, Andreas [1 ]
Schroeder, Stefan [2 ]
Gehrt, Anna [3 ]
Bernhardt, Kathrin [3 ]
Bein, Berthold [4 ]
Wegscheider, Karl [5 ]
Hochreiter, Marcel [6 ]
机构
[1] Ruhr Univ Bochum, BG Univ Hosp Bergmannsheil, Dept Anaesthesiol Intens Care Palliat Care & Pain, D-44789 Bochum, Germany
[2] Hosp Duren Gem GmbH, Dept Anaesthesiol Intens Care Med & Pain Therapy, D-52351 Duren, Germany
[3] West Coast Hosp, Dept Anesthesiol & Intens Care Med, D-25746 Heide, Germany
[4] Univ Hosp Schleswig Holstein, Dept Anesthesiol & Intens Care Med, D-24105 Kiel, Germany
[5] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, D-20246 Hamburg, Germany
[6] Univ Heidelberg Hosp, Dept Anesthesiol, D-69120 Heidelberg, Germany
关键词
Procalcitonin; Sepsis; Economical outcomes; Intensive care; RESPIRATORY-TRACT INFECTIONS; VENTILATOR-ASSOCIATED PNEUMONIA; INTENSIVE-CARE PATIENTS; ANTIMICROBIAL RESISTANCE; DISEASES-SOCIETY; CONTROLLED-TRIAL; DURATION; GUIDELINES; EPIDEMIOLOGY; INITIATION;
D O I
10.1186/1471-2334-13-158
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Procalcitonin (PCT)-protocols to guide antibiotic treatment in severe infections are known to be effective. But less is known about the long-term effects of such protocols on antibiotic consumption under real life conditions. This retrospective study analyses the effects on antibiotic use in patients with severe sepsis and septic shock after implementation of a PCT-protocol. Methods: We conducted a retrospective ICU-database search for adult patients between 2005 and 2009 with sepsis and organ dysfunction who where treated accordingly to a PCT-guided algorithm as follows: Daily measurements of PCT (BRAHMS PCT LIA (R); BRAHMS Aktiengesellschaft, Hennigsdorf, Germany). Antibiotic therapy was discontinued if 1) clinical signs and symptoms of infection improved and PCT decreased to <= 1 ng/ml, or 2) if the PCT value was >1 ng/ml, but had dropped to 25-35% of the initial value within three days. The primary outcome parameters were: antibiotic days on ICU, ICU re-infection rate, 28-day mortality rate, length of stay (LOS) in ICU, mean antibiotic costs (per patient) and ventilation hours. Data from 141 patients were included in our study. Primary outcome parameters were analysed using covariance analyses (ANCOVA) to control for effects by gender, age, SAPS II, APACHE II and effective cost weight. Results: From baseline data of 2005, duration of antibiotic therapy was reduced by an average of 1.0 day per year from 14.3 +/- 1.2 to 9.0 +/- 1.7 days in 2009 (p=0.02). ICU re-infection rate was decreased by yearly 35.1% (95% CI -53 to -8.5; p=0.014) just as ventilation hours by 42 hours per year (95% CI -72.6 to -11.4; p=0.008). ICU-LOS was reduced by 2.7 days per year (p<0.001). Trends towards an average yearly reduction of 28-day mortality by -22.4% (95% CI -44.3 to 8.1; p=0.133) and mean cost for antibiotic therapy/patient by -14.3 Euro (95% CI -55.7 to 27.1) did not reach statistical significance. Conclusions: In a real-life clinical setting, implementation of a PCT-protocol was associated with a reduced duration of antibiotic therapy in septic ICU patients without compromising clinical or economical outcomes.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] SERUM PROCALCITONIN LEVELS IN SEVERE SEPSIS AND SEPTIC SHOCK
    Garcia Olivares, P.
    Diaz, M.
    De Sousa, I. A.
    Tang, L.
    Estevez, M. A.
    Ramirez, C.
    Caciano, C.
    Bocanegra, C.
    Keough, E.
    Dalorzo, M.
    INTENSIVE CARE MEDICINE, 2013, 39 : S342 - S343
  • [32] Is Procalcitonin-Guided Antibiotic Therapy Working in Emergency Department Outpatients?
    Bolliger, Rebekka
    Merker, Meret
    Wirz, Yannick
    Mueller, Beat
    Schuetz, Philipp
    ANNALS OF EMERGENCY MEDICINE, 2018, 72 (02) : 226 - 228
  • [33] Procalcitonin as a prognostic biomarker of severe sepsis and septic shock
    JRA de Azevedo
    OJM Torres
    O Malafaia
    Critical Care, 17 (Suppl 3):
  • [34] Procalcitonin-guided antibiotic therapy: a potentially effective and efficient strategy
    Plebani, Mario
    Fabbri, Leonardo M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2015, 53 (04) : 519 - 520
  • [35] Overview of procalcitonin assays and procalcitonin-guided protocols for the management of patients with infections and sepsis
    Schuetz, Philipp
    Bretscher, Celine
    Bernasconi, Luca
    Mueller, Beat
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2017, 17 (06) : 593 - 601
  • [36] Procalcitonin-guided antibiotic prescribing did not reduce antibiotic use in suspected LRTI in the ED
    Tansarli, Giannoula S.
    Mylonakis, Eleftherios
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (08) : JC39 - JC39
  • [37] Procalcitonin-guided antibiotic therapy in COPD exacerbations - Closer but not quitethere
    Martinez, Ferriatido J.
    CuTtis, Jeffirey L.
    CHEST, 2007, 131 (01) : 1 - 2
  • [38] Procalcitonin-Guided Antibiotic Therapy Duration in Critically Ill Adults
    Walker, Caroline
    AACN ADVANCED CRITICAL CARE, 2015, 26 (02) : 99 - 106
  • [39] Early and adequate antibiotic therapy in the treatment of severe sepsis and septic shock
    Dickinson J.D.
    Kollef M.H.
    Current Infectious Disease Reports, 2011, 13 (5) : 399 - 405
  • [40] Corticosteroid therapy in patients with severe sepsis and septic shock
    Keh, D
    Goodman, S
    Sprung, CL
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 25 (06) : 713 - 719